₹198.11
Above FV▼ -39.6% against the close used
Model range ₹54.67 – ₹259.87
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear₹54.67Fair value₹198.11Bull₹259.87
FairClose
52-week traded range
52W low ₹227.9552W high ₹340.80
The 52-week range is measured from the stored price history, not estimated.
Trading above the consensus fair value
Suraksha Diagnostic Ltd closed at ₹327.85, 65.5% above the consensus fair value of ₹198.11 drawn from 7 valuation models.
Financial DNA score 34/100 — Weak. P/E of 47.1x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
₹54.67
-83.3%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₹85.82
-73.8%
√(22.5 × EPS × BVPS)
EPS=6.18, BVPS=52.96 · outside Graham range (P/E 47.1, P/B 6.2) — asset-light, treat as a rough floor
P/E Fair Value
₹259.87
-20.7%
EPS × 42.05x (sector P/E)
EPS=6.18, Sector P/E=42.05x
EV/EBITDA
₹241.12
-26.5%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=1.37B
Book Value (P/B)
₹84.74
-74.2%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=52.96, ROE=14.2%, g=3%, r=10%
Reverse DCF
₹327.85
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 20.3% | Historical: 0%
Margin of Safety
₹100.09
-69.5%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=133.45, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.